Juliet Richman

3PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 06, 2024
Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients.

Juliet Richman, Gene Schuster, Richard Buus

|Nov 22, 2020
Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer.

Juliet Richman, Alistair Ring, Mitch Dowsett

|Dec 20, 2018
Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer.

Juliet Richman, Mitch Dowsett

Pageof 1

Frequent Collaborators